Srivastava, P., Tiwari, A., Trivedi, A., , Pant, A., & Saxena, S. (1969). Virtual Screening of Natural and Synthetic Ligands Against Diabetic Retinopathy by Molecular Interaction With Angiopoietin-2. Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.), 3(4), 257-9. https://doi.org/10.1097/APO.0000000000000071 (Original work published 1969)

Tiwari, A., Saxena, S., Pant, A., & Srivastava, P. Protein-ligand interaction studies of retinol-binding protein 3 with herbal molecules using AutoDock for the management of Eales’ disease. Journal of Ocular Biology, Diseases, and Informatics, 5(2), 40-3. https://doi.org/10.1007/s12177-012-9098-6 (Original work published 2012)

Saxena, S., Khanna, V., Pant, A., Meyer, C., & Singh, V. Elevated tumor necrosis factor in serum is associated with increased retinal ischemia in proliferative eales’ disease. Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology, 78(5), 261-5. https://doi.org/10.1159/000329589 (Original work published 2011)

Saxena, S., Pant, A., Khanna, V., Singh, K., Shukla, R., Meyer, C., & Singh, V. (2010). Tumor necrosis factor-α-mediated severity of idiopathic retinal periphlebitis in young adults (Eales’ disease): implication for anti-TNF-α therapy. Journal of Ocular Biology, Diseases, and Informatics, 3(1), 35-8. https://doi.org/10.1007/s12177-010-9053-3 (Original work published 2010)

Tiwari, A., Trivedi, A., Srivastava, P., Pant, A., & Saxena, S. (2010). Comparative modeling of retinol-binding protein-3 and retinal S-antigen in Eales’ disease and prediction of their binding sites using computational methods. Journal of Ocular Biology, Diseases, and Informatics, 3(3), 88-91. https://doi.org/10.1007/s12177-011-9060-z

Saxena, S., Pant, A., Khanna, V., Agarwal, A., Singh, K., Kumar, D., & Singh, V. (1969). Interleukin-1 and tumor necrosis factor-alpha: novel targets for immunotherapy in Eales disease. Ocular Immunology and Inflammation, 17(3), 201-6. https://doi.org/10.1080/09273940902731015 (Original work published 1969)